Mbl Wealth, LLC Bristol Myers Squibb CO Transaction History

Mbl Wealth, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $26,421 - $31,528	545 Added 14.94%	4,193 $215,000
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $6,425 - $7,185	-111 Reduced 2.95%	3,648 $211,000
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $16,755 - $18,604	-263 Reduced 6.54%	3,759 $240,000
Q1 2023 Apr 11, 2023	BUY	$65.71 - $74.53 $44,748 - $50,754	681 Added 20.38%	4,022 $278,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $2,739 - $3,243	-40 Reduced 1.18%	3,341 $240,000
Q3 2022 Jan 12, 2023	BUY	$0.13 - $76.84 $5 - $3,073	40 Added 1.2%	3,381 $240,000
Q2 2022 Jan 12, 2023	SELL	$72.62 - $79.98 $76,541 - $84,298	-1,054 Reduced 23.98%	3,341 $257,000
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $270,204 - $323,999	4,395 New	4,395 $321,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $223,011 - $261,229	-3,769 Closed	0 $0
Q1 2021 May 27, 2021	BUY	$59.34 - $66.74 $16,021 - $18,019	270 Added 7.72%	3,769 $238,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $202,032 - $228,939	3,499 New	3,499 $217,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mbl Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Mbl Wealth, LLC with notifications on news.